B. Thuerlimann

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study

Florian Strasser, Thomas A. Lutz, Micha T. Maeder et al. · British Journal of Cancer · 2008 · 160 citations · Full text

BIG 1-98: A randomized double-blind phase III study evaluating letrozole and tamoxifen given in sequence as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer.

H.T. Mouridsen, Anita Giobbie‐Hurder, L. Mauriac et al. · Cancer Research · 2009 · 41 citations

Breast Oncology, Cancer Management, Gynecology +21

Docetaxel vs mitomycin plus vinblastine in anthracycline-resistant metastatic breast cancer.

J.-M. Nabholtz, B. Thuerlimann, W.R. Bezwoda et al. · PubMed · 1997 · 34 citations

Breast Oncology, Docetaxel Vs Mitomycin, Medicine +13

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer

M. Lehnert, K. Mross, J. Schueller et al. · British Journal of Cancer · 1998 · 32 citations · Full text

Breast Oncology, Phase Ii Trial, Medicine +5

Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.

Giuseppe Viale, MM Regan, Patrizia Dell’Orto et al. · Cancer Research · 2009 · 23 citations

Breast Oncology, Gynecology, Pharmacotherapy +20